It is likely that most, if not all, of the relevant genomic abnormalities in AML ... these hypotheses cannot be overemphasized. AML: Acute myeloid leukemia; APL: Acute promyelocytic leukemia ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

Researchers have led a global study that identified molecular predictors of survival among Black patients with acute myeloid ...

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against ...

A GENETIC variant, the BIM deletion polymorphism (BDP), has been identified by researchers to significantly enhance leukemia ...

Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) led a global study that identified ...

Leukemia occurs when the bone marrow begins to produce abnormal cells. This happens when the bone marrow cells' genetic material ... to an increased risk of acute myeloid leukemia (AML).

Oct. 9, 2024 — Researchers have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately ...

Recent advances in prognostic factors in AML have led to changes in the diagnostic ... that are able to take advantage of the leukemia's genetic abnormalities. This lag between novel discoveries ...

Scientists from Duke-NUS Medical School and their collaborators have identified an inherited genetic variation prevalent ... for adults with acute myeloid leukemia (AML) or myelodysplastic ...